Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity & Safety of Priorix-Tetra in Korean Toddlers
NCT00751348Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2008
- Primary completion
- May 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of GSK208136 in measles, mumps, rubella, varicella (VZV), sponsored by GSK. Started Oct 2008; status: completed.
02
Drugs
GSK208136
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00751348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751348.